Clinical Trials Related to GlaxoSmithKline

Related studies linked through entity extraction aliases.

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

Status: COMPLETED
Phase: PHASE3

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status: COMPLETED
Phase: PHASE3

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Status: COMPLETED
Phase: PHASE2

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Status: COMPLETED
Phase: PHASE2

Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor

Status: COMPLETED
Phase: NA

Study in Allergic Adults to Support the Development of Immunological Assays

Status: COMPLETED
Phase: NA

A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status: COMPLETED
Phase: PHASE2

Relative Bioavailability Study for GSK1278863A

Status: COMPLETED
Phase: PHASE1

Open-Label Extension Study of GSK1605786A

Status: TERMINATED
Phase: PHASE3

A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A

Status: COMPLETED
Phase: PHASE1

Surveillance for Adverse Events Following Influenza Immunization

Status: COMPLETED
Phase: N/A

A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

Status: WITHDRAWN
Phase: N/A

Coreg and HSRs-Updated Analysis

Status: COMPLETED
Phase: N/A

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

Status: TERMINATED
Phase: PHASE3

Paxil CR Bioequivalence Study Brazil

Status: COMPLETED
Phase: PHASE1

24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease

Status: COMPLETED
Phase: PHASE3

24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

Status: COMPLETED
Phase: PHASE3

A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Status: COMPLETED
Phase: PHASE3

Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Status: COMPLETED
Phase: PHASE3

A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population

Status: TERMINATED
Phase: PHASE2